FREEBIRD PARTNERS LP enters ERNEXA THERAPEUTICS INC. with 272.58K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/4/2023ACC: 0000899243-23-010438
10% Owner
Since Apr 2023
272.58K
Baseline shares
100% direct
272.58K
Direct ownership
1 position
424.93K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.005 per share
DirectShares owned272.58K
Total
272.58K direct272.58K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.005 per share | 272.58K | Direct |
| Total | 272.58K | 272.58K direct |
Derivative Holdings1
Common Stock Purchase Warrant
DirectUnderlying security
Common Stock, par value $0.005 per share
Underlying shares
424.93K
Shares owned
N/A
Exercise price
3.28
Expiration
—
Exercise window
—
Total
Underlying
424.93K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Common Stock Purchase Warrant Direct | Common Stock, par value $0.005 per share | 3.28 | — | — | 424.93K | N/A |
| Total | 424.93K | 0.00 | ||||